This is important in terms of treatment and survival because it has been reported that pancreatic cancer patients with an elevated FGFR2 expression have a shorter survival time relative to those with low FGFR2 expression (Nomura et al., 2008[27]). The gene discussed is FGFR2; the disease is familial pancreatic carcinoma.